Compile Data Set for Download or QSAR

Found 44 hits Enz. Inhib. hit(s) with all data for entry = 9547   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Tyrosine-protein kinase HCK (Homo sapiens (Human))	BDBM473766 (US10844077, Compound I-9) Show SMILES CCC(=O)N1CC[C@@H](C1)Nc1nccc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2C)n1 |r| Show InChI InChI=1S/C23H27N7O2S/c1-4-19(31)30-11-9-16(13-30)26-22-24-10-8-18(27-22)28-23-25-12-17(33-23)21(32)29-20-14(2)6-5-7-15(20)3/h5-8,10,12,16H,4,9,11,13H2,1-3H3,(H,29,32)(H2,24,25,26,27,28)/t16-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<0.495	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM473764 (US10844077, Compound II-2) Show SMILES Cc1cccc(Cl)c1NC(=O)c1cnc(Nc2ccn(CC3CCCN(C3)C(=O)C=C)n2)s1 Show InChI InChI=1S/C23H25ClN6O2S/c1-3-20(31)29-10-5-7-16(13-29)14-30-11-9-19(28-30)26-23-25-12-18(33-23)22(32)27-21-15(2)6-4-8-17(21)24/h3-4,6,8-9,11-12,16H,1,5,7,10,13-14H2,2H3,(H,27,32)(H,25,26,28)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<0.495	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase HCK (Homo sapiens (Human))	BDBM473746 (US10844077, Compound I-3) Show SMILES Cc1cccc(C)c1NC(=O)c1cnc(Nc2ccnc(N[C@H]3CCN(C3)C(=O)C=C)n2)s1 |r| Show InChI InChI=1S/C23H25N7O2S/c1-4-19(31)30-11-9-16(13-30)26-22-24-10-8-18(27-22)28-23-25-12-17(33-23)21(32)29-20-14(2)6-5-7-15(20)3/h4-8,10,12,16H,1,9,11,13H2,2-3H3,(H,29,32)(H2,24,25,26,27,28)/t16-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<0.495	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase HCK (Homo sapiens (Human))	BDBM473751 (US10844077, Compound I-8) Show SMILES Cc1cccc(C)c1NC(=O)c1cnc(Nc2ccnc(NCC3CCN(C3)C(=O)C=C)n2)s1 Show InChI InChI=1S/C24H27N7O2S/c1-4-20(32)31-11-9-17(14-31)12-26-23-25-10-8-19(28-23)29-24-27-13-18(34-24)22(33)30-21-15(2)6-5-7-16(21)3/h4-8,10,13,17H,1,9,11-12,14H2,2-3H3,(H,30,33)(H2,25,26,27,28,29)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<0.495	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM473751 (US10844077, Compound I-8) Show SMILES Cc1cccc(C)c1NC(=O)c1cnc(Nc2ccnc(NCC3CCN(C3)C(=O)C=C)n2)s1 Show InChI InChI=1S/C24H27N7O2S/c1-4-20(32)31-11-9-17(14-31)12-26-23-25-10-8-19(28-23)29-24-27-13-18(34-24)22(33)30-21-15(2)6-5-7-16(21)3/h4-8,10,13,17H,1,9,11-12,14H2,2-3H3,(H,30,33)(H2,25,26,27,28,29)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<0.495	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase HCK (Homo sapiens (Human))	BDBM473750 (US10844077, Compound I-7) Show SMILES Cc1cccc(C)c1NC(=O)c1cnc(Nc2ccnc(NC3CCCCN(C3)C(=O)C=C)n2)s1 Show InChI InChI=1S/C25H29N7O2S/c1-4-21(33)32-13-6-5-10-18(15-32)28-24-26-12-11-20(29-24)30-25-27-14-19(35-25)23(34)31-22-16(2)8-7-9-17(22)3/h4,7-9,11-12,14,18H,1,5-6,10,13,15H2,2-3H3,(H,31,34)(H2,26,27,28,29,30)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<0.495	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM473750 (US10844077, Compound I-7) Show SMILES Cc1cccc(C)c1NC(=O)c1cnc(Nc2ccnc(NC3CCCCN(C3)C(=O)C=C)n2)s1 Show InChI InChI=1S/C25H29N7O2S/c1-4-21(33)32-13-6-5-10-18(15-32)28-24-26-12-11-20(29-24)30-25-27-14-19(35-25)23(34)31-22-16(2)8-7-9-17(22)3/h4,7-9,11-12,14,18H,1,5-6,10,13,15H2,2-3H3,(H,31,34)(H2,26,27,28,29,30)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<0.495	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM473766 (US10844077, Compound I-9) Show SMILES CCC(=O)N1CC[C@@H](C1)Nc1nccc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2C)n1 |r| Show InChI InChI=1S/C23H27N7O2S/c1-4-19(31)30-11-9-16(13-30)26-22-24-10-8-18(27-22)28-23-25-12-17(33-23)21(32)29-20-14(2)6-5-7-15(20)3/h5-8,10,12,16H,4,9,11,13H2,1-3H3,(H,29,32)(H2,24,25,26,27,28)/t16-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.5	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase HCK (Homo sapiens (Human))	BDBM473701 (US10844077, Compound I-1) Show SMILES Cc1cccc(Cl)c1NC(=O)c1cnc(Nc2cc(CN3CCOCC3)nc(N[C@H]3CCN(C3)C(=O)C=C)n2)s1 |r| Show InChI InChI=1S/C27H31ClN8O3S/c1-3-23(37)36-8-7-18(16-36)30-26-31-19(15-35-9-11-39-12-10-35)13-22(32-26)33-27-29-14-21(40-27)25(38)34-24-17(2)5-4-6-20(24)28/h3-6,13-14,18H,1,7-12,15-16H2,2H3,(H,34,38)(H2,29,30,31,32,33)/t18-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.590	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase HCK (Homo sapiens (Human))	BDBM473749 (US10844077, Compound I-4) Show SMILES Cc1cccc(C)c1NC(=O)c1cnc(Nc2ccnc(N[C@@H]3CCN(C3)C(=O)C=C)n2)s1 |r| Show InChI InChI=1S/C23H25N7O2S/c1-4-19(31)30-11-9-16(13-30)26-22-24-10-8-18(27-22)28-23-25-12-17(33-23)21(32)29-20-14(2)6-5-7-15(20)3/h4-8,10,12,16H,1,9,11,13H2,2-3H3,(H,29,32)(H2,24,25,26,27,28)/t16-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.590	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM473746 (US10844077, Compound I-3) Show SMILES Cc1cccc(C)c1NC(=O)c1cnc(Nc2ccnc(N[C@H]3CCN(C3)C(=O)C=C)n2)s1 |r| Show InChI InChI=1S/C23H25N7O2S/c1-4-19(31)30-11-9-16(13-30)26-22-24-10-8-18(27-22)28-23-25-12-17(33-23)21(32)29-20-14(2)6-5-7-15(20)3/h4-8,10,12,16H,1,9,11,13H2,2-3H3,(H,29,32)(H2,24,25,26,27,28)/t16-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.600	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase HCK (Homo sapiens (Human))	BDBM473748 (US10844077, Compound I-2) Show SMILES Cc1cccc(C)c1NC(=O)c1cnc(Nc2cc(CN3CCOCC3)nc(N[C@H]3CCN(C3)C(=O)C=C)n2)s1 |r| Show InChI InChI=1S/C28H34N8O3S/c1-4-24(37)36-9-8-20(17-36)30-27-31-21(16-35-10-12-39-13-11-35)14-23(32-27)33-28-29-15-22(40-28)26(38)34-25-18(2)6-5-7-19(25)3/h4-7,14-15,20H,1,8-13,16-17H2,2-3H3,(H,34,38)(H2,29,30,31,32,33)/t20-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.730	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM473763 (US10844077, Compound II-1) Show SMILES Cc1cccc(Cl)c1NC(=O)c1cnc(Nc2ccn(CC3CCN(C3)C(=O)C=C)n2)s1 Show InChI InChI=1S/C22H23ClN6O2S/c1-3-19(30)28-9-7-15(12-28)13-29-10-8-18(27-29)25-22-24-11-17(32-22)21(31)26-20-14(2)5-4-6-16(20)23/h3-6,8,10-11,15H,1,7,9,12-13H2,2H3,(H,26,31)(H,24,25,27)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.10	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM473749 (US10844077, Compound I-4) Show SMILES Cc1cccc(C)c1NC(=O)c1cnc(Nc2ccnc(N[C@@H]3CCN(C3)C(=O)C=C)n2)s1 |r| Show InChI InChI=1S/C23H25N7O2S/c1-4-19(31)30-11-9-16(13-30)26-22-24-10-8-18(27-22)28-23-25-12-17(33-23)21(32)29-20-14(2)6-5-7-15(20)3/h4-8,10,12,16H,1,9,11,13H2,2-3H3,(H,29,32)(H2,24,25,26,27,28)/t16-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.38	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM473701 (US10844077, Compound I-1) Show SMILES Cc1cccc(Cl)c1NC(=O)c1cnc(Nc2cc(CN3CCOCC3)nc(N[C@H]3CCN(C3)C(=O)C=C)n2)s1 |r| Show InChI InChI=1S/C27H31ClN8O3S/c1-3-23(37)36-8-7-18(16-36)30-26-31-19(15-35-9-11-39-12-10-35)13-22(32-26)33-27-29-14-21(40-27)25(38)34-24-17(2)5-4-6-20(24)28/h3-6,13-14,18H,1,7-12,15-16H2,2H3,(H,34,38)(H2,29,30,31,32,33)/t18-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.61	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM473748 (US10844077, Compound I-2) Show SMILES Cc1cccc(C)c1NC(=O)c1cnc(Nc2cc(CN3CCOCC3)nc(N[C@H]3CCN(C3)C(=O)C=C)n2)s1 |r| Show InChI InChI=1S/C28H34N8O3S/c1-4-24(37)36-9-8-20(17-36)30-27-31-21(16-35-10-12-39-13-11-35)14-23(32-27)33-28-29-15-22(40-28)26(38)34-25-18(2)6-5-7-19(25)3/h4-7,14-15,20H,1,8-13,16-17H2,2-3H3,(H,34,38)(H2,29,30,31,32,33)/t20-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.63	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase HCK (Homo sapiens (Human))	BDBM473763 (US10844077, Compound II-1) Show SMILES Cc1cccc(Cl)c1NC(=O)c1cnc(Nc2ccn(CC3CCN(C3)C(=O)C=C)n2)s1 Show InChI InChI=1S/C22H23ClN6O2S/c1-3-19(30)28-9-7-15(12-28)13-29-10-8-18(27-29)25-22-24-11-17(32-22)21(31)26-20-14(2)5-4-6-16(20)23/h3-6,8,10-11,15H,1,7,9,12-13H2,2H3,(H,26,31)(H,24,25,27)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.64	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM473752 (US10844077, Compound I-10) Show SMILES Cc1cccc(Cl)c1NC(=O)c1cnc(Nc2ccnc(N[C@H]3CCN(C3)C(=O)C=C)n2)s1 |r| Show InChI InChI=1S/C22H22ClN7O2S/c1-3-18(31)30-10-8-14(12-30)26-21-24-9-7-17(27-21)28-22-25-11-16(33-22)20(32)29-19-13(2)5-4-6-15(19)23/h3-7,9,11,14H,1,8,10,12H2,2H3,(H,29,32)(H2,24,25,26,27,28)/t14-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.74	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM473747 (US10844077, Compound I-6) Show SMILES Cc1cccc(C)c1NC(=O)c1cnc(Nc2ccnc(N[C@@H]3CCCN(C3)C(=O)C=C)n2)s1 |r| Show InChI InChI=1S/C24H27N7O2S/c1-4-20(32)31-12-6-9-17(14-31)27-23-25-11-10-19(28-23)29-24-26-13-18(34-24)22(33)30-21-15(2)7-5-8-16(21)3/h4-5,7-8,10-11,13,17H,1,6,9,12,14H2,2-3H3,(H,30,33)(H2,25,26,27,28,29)/t17-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.90	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase HCK (Homo sapiens (Human))	BDBM473764 (US10844077, Compound II-2) Show SMILES Cc1cccc(Cl)c1NC(=O)c1cnc(Nc2ccn(CC3CCCN(C3)C(=O)C=C)n2)s1 Show InChI InChI=1S/C23H25ClN6O2S/c1-3-20(31)29-10-5-7-16(13-29)14-30-11-9-19(28-30)26-23-25-12-18(33-23)22(32)27-21-15(2)6-4-8-17(21)24/h3-4,6,8-9,11-12,16H,1,5,7,10,13-14H2,2H3,(H,27,32)(H,25,26,28)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.94	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase HCK (Homo sapiens (Human))	BDBM473752 (US10844077, Compound I-10) Show SMILES Cc1cccc(Cl)c1NC(=O)c1cnc(Nc2ccnc(N[C@H]3CCN(C3)C(=O)C=C)n2)s1 |r| Show InChI InChI=1S/C22H22ClN7O2S/c1-3-18(31)30-10-8-14(12-30)26-21-24-9-7-17(27-21)28-22-25-11-16(33-22)20(32)29-19-13(2)5-4-6-15(19)23/h3-7,9,11,14H,1,8,10,12H2,2H3,(H,29,32)(H2,24,25,26,27,28)/t14-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.42	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase HCK (Homo sapiens (Human))	BDBM473753 (US10844077, Compound I-11) Show SMILES Cc1cccc(Cl)c1NC(=O)c1cnc(Nc2ccnc(NC3CCCCN(C3)C(=O)C=C)n2)s1 Show InChI InChI=1S/C24H26ClN7O2S/c1-3-20(33)32-12-5-4-8-16(14-32)28-23-26-11-10-19(29-23)30-24-27-13-18(35-24)22(34)31-21-15(2)7-6-9-17(21)25/h3,6-7,9-11,13,16H,1,4-5,8,12,14H2,2H3,(H,31,34)(H2,26,27,28,29,30)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3.99	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase HCK (Homo sapiens (Human))	BDBM473747 (US10844077, Compound I-6) Show SMILES Cc1cccc(C)c1NC(=O)c1cnc(Nc2ccnc(N[C@@H]3CCCN(C3)C(=O)C=C)n2)s1 |r| Show InChI InChI=1S/C24H27N7O2S/c1-4-20(32)31-12-6-9-17(14-31)27-23-25-11-10-19(28-23)29-24-26-13-18(34-24)22(33)30-21-15(2)7-5-8-16(21)3/h4-5,7-8,10-11,13,17H,1,6,9,12,14H2,2-3H3,(H,30,33)(H2,25,26,27,28,29)/t17-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	4.24	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM473753 (US10844077, Compound I-11) Show SMILES Cc1cccc(Cl)c1NC(=O)c1cnc(Nc2ccnc(NC3CCCCN(C3)C(=O)C=C)n2)s1 Show InChI InChI=1S/C24H26ClN7O2S/c1-3-20(33)32-12-5-4-8-16(14-32)28-23-26-11-10-19(29-23)30-24-27-13-18(35-24)22(34)31-21-15(2)7-6-9-17(21)25/h3,6-7,9-11,13,16H,1,4-5,8,12,14H2,2H3,(H,31,34)(H2,26,27,28,29,30)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5.52	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM473758 (US10844077, Compound III-5) Show SMILES C=CC(=O)N1CCCCC(C1)Nc1nccc(Nc2nc3ccc(Oc4ccccc4)nc3s2)n1 Show InChI InChI=1S/C25H25N7O2S/c1-2-22(33)32-15-7-6-8-17(16-32)27-24-26-14-13-20(29-24)30-25-28-19-11-12-21(31-23(19)35-25)34-18-9-4-3-5-10-18/h2-5,9-14,17H,1,6-8,15-16H2,(H2,26,27,28,29,30)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	9.06	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM473756 (US10844077, Compound III-3) Show SMILES C=CC(=O)N1CCC[C@@H](C1)Nc1nccc(Nc2nc3ccc(Oc4ccccc4)nc3s2)n1 |r| Show InChI InChI=1S/C24H23N7O2S/c1-2-21(32)31-14-6-7-16(15-31)26-23-25-13-12-19(28-23)29-24-27-18-10-11-20(30-22(18)34-24)33-17-8-4-3-5-9-17/h2-5,8-13,16H,1,6-7,14-15H2,(H2,25,26,27,28,29)/t16-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	19.4	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM473765 (US10844077, Compound II-3) Show SMILES Cc1cccc(Cl)c1NC(=O)c1cnc(Nc2cnn(c2)C2CCN(CC2)C(=O)C=C)s1 Show InChI InChI=1S/C22H23ClN6O2S/c1-3-19(30)28-9-7-16(8-10-28)29-13-15(11-25-29)26-22-24-12-18(32-22)21(31)27-20-14(2)5-4-6-17(20)23/h3-6,11-13,16H,1,7-10H2,2H3,(H,24,26)(H,27,31)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	19.9	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase HCK (Homo sapiens (Human))	BDBM473765 (US10844077, Compound II-3) Show SMILES Cc1cccc(Cl)c1NC(=O)c1cnc(Nc2cnn(c2)C2CCN(CC2)C(=O)C=C)s1 Show InChI InChI=1S/C22H23ClN6O2S/c1-3-19(30)28-9-7-16(8-10-28)29-13-15(11-25-29)26-22-24-12-18(32-22)21(31)27-20-14(2)5-4-6-17(20)23/h3-6,11-13,16H,1,7-10H2,2H3,(H,24,26)(H,27,31)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	25.3	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM473754 (US10844077, Compound III-1) Show SMILES C=CC(=O)N1CC[C@@H](C1)Nc1nccc(Nc2nc3ccc(Oc4ccccc4)nc3s2)n1 |r| Show InChI InChI=1S/C23H21N7O2S/c1-2-20(31)30-13-11-15(14-30)25-22-24-12-10-18(27-22)28-23-26-17-8-9-19(29-21(17)33-23)32-16-6-4-3-5-7-16/h2-10,12,15H,1,11,13-14H2,(H2,24,25,26,27,28)/t15-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	86.6	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM473755 (US10844077, Compound III-2) Show SMILES C=CC(=O)N1CC[C@H](C1)Nc1nccc(Nc2nc3ccc(Oc4ccccc4)nc3s2)n1 |r| Show InChI InChI=1S/C23H21N7O2S/c1-2-20(31)30-13-11-15(14-30)25-22-24-12-10-18(27-22)28-23-26-17-8-9-19(29-21(17)33-23)32-16-6-4-3-5-7-16/h2-10,12,15H,1,11,13-14H2,(H2,24,25,26,27,28)/t15-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	281	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM473757 (US10844077, Compound III-4) Show SMILES C=CC(=O)N1CCC[C@H](C1)Nc1nccc(Nc2nc3ccc(Oc4ccccc4)nc3s2)n1 |r| Show InChI InChI=1S/C24H23N7O2S/c1-2-21(32)31-14-6-7-16(15-31)26-23-25-13-12-19(28-23)29-24-27-18-10-11-20(30-22(18)34-24)33-17-8-4-3-5-9-17/h2-5,8-13,16H,1,6-7,14-15H2,(H2,25,26,27,28,29)/t16-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	367	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase HCK (Homo sapiens (Human))	BDBM473755 (US10844077, Compound III-2) Show SMILES C=CC(=O)N1CC[C@H](C1)Nc1nccc(Nc2nc3ccc(Oc4ccccc4)nc3s2)n1 |r| Show InChI InChI=1S/C23H21N7O2S/c1-2-20(31)30-13-11-15(14-30)25-22-24-12-10-18(27-22)28-23-26-17-8-9-19(29-21(17)33-23)32-16-6-4-3-5-7-16/h2-10,12,15H,1,11,13-14H2,(H2,24,25,26,27,28)/t15-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	402	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase HCK (Homo sapiens (Human))	BDBM473757 (US10844077, Compound III-4) Show SMILES C=CC(=O)N1CCC[C@H](C1)Nc1nccc(Nc2nc3ccc(Oc4ccccc4)nc3s2)n1 |r| Show InChI InChI=1S/C24H23N7O2S/c1-2-21(32)31-14-6-7-16(15-31)26-23-25-13-12-19(28-23)29-24-27-18-10-11-20(30-22(18)34-24)33-17-8-4-3-5-9-17/h2-5,8-13,16H,1,6-7,14-15H2,(H2,25,26,27,28,29)/t16-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.15E+3	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase HCK (Homo sapiens (Human))	BDBM473754 (US10844077, Compound III-1) Show SMILES C=CC(=O)N1CC[C@@H](C1)Nc1nccc(Nc2nc3ccc(Oc4ccccc4)nc3s2)n1 |r| Show InChI InChI=1S/C23H21N7O2S/c1-2-20(31)30-13-11-15(14-30)25-22-24-12-10-18(27-22)28-23-26-17-8-9-19(29-21(17)33-23)32-16-6-4-3-5-7-16/h2-10,12,15H,1,11,13-14H2,(H2,24,25,26,27,28)/t15-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.82E+3	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase HCK (Homo sapiens (Human))	BDBM473758 (US10844077, Compound III-5) Show SMILES C=CC(=O)N1CCCCC(C1)Nc1nccc(Nc2nc3ccc(Oc4ccccc4)nc3s2)n1 Show InChI InChI=1S/C25H25N7O2S/c1-2-22(33)32-15-7-6-8-17(16-32)27-24-26-14-13-20(29-24)30-25-28-19-11-12-21(31-23(19)35-25)34-18-9-4-3-5-10-18/h2-5,9-14,17H,1,6-8,15-16H2,(H2,26,27,28,29,30)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.91E+3	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase HCK (Homo sapiens (Human))	BDBM473756 (US10844077, Compound III-3) Show SMILES C=CC(=O)N1CCC[C@@H](C1)Nc1nccc(Nc2nc3ccc(Oc4ccccc4)nc3s2)n1 |r| Show InChI InChI=1S/C24H23N7O2S/c1-2-21(32)31-14-6-7-16(15-31)26-23-25-13-12-19(28-23)29-24-27-18-10-11-20(30-22(18)34-24)33-17-8-4-3-5-9-17/h2-5,8-13,16H,1,6-7,14-15H2,(H2,25,26,27,28,29)/t16-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.15E+3	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM473759 (US10844077, Compound III-6) Show SMILES Cn1ccc(Nc2nc3ccc(Oc4ccccc4)nc3s2)n1 Show InChI InChI=1S/C16H13N5OS/c1-21-10-9-13(20-21)18-16-17-12-7-8-14(19-15(12)23-16)22-11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18,20)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.58E+3	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM473762 (US10844077, Compound III-9) Show SMILES C1CC(CCN1)n1cc(Nc2nc3ccc(Oc4ccccc4)nc3s2)cn1 Show InChI InChI=1S/C20H20N6OS/c1-2-4-16(5-3-1)27-18-7-6-17-19(25-18)28-20(24-17)23-14-12-22-26(13-14)15-8-10-21-11-9-15/h1-7,12-13,15,21H,8-11H2,(H,23,24)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.66E+3	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase HCK (Homo sapiens (Human))	BDBM473759 (US10844077, Compound III-6) Show SMILES Cn1ccc(Nc2nc3ccc(Oc4ccccc4)nc3s2)n1 Show InChI InChI=1S/C16H13N5OS/c1-21-10-9-13(20-21)18-16-17-12-7-8-14(19-15(12)23-16)22-11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18,20)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	4.55E+3	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase HCK (Homo sapiens (Human))	BDBM473762 (US10844077, Compound III-9) Show SMILES C1CC(CCN1)n1cc(Nc2nc3ccc(Oc4ccccc4)nc3s2)cn1 Show InChI InChI=1S/C20H20N6OS/c1-2-4-16(5-3-1)27-18-7-6-17-19(25-18)28-20(24-17)23-14-12-22-26(13-14)15-8-10-21-11-9-15/h1-7,12-13,15,21H,8-11H2,(H,23,24)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	7.20E+3	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase HCK (Homo sapiens (Human))	BDBM473761 (US10844077, Compound III-8) Show SMILES C1CC(CCO1)n1cc(Nc2nc3ccc(Oc4ccccc4)nc3s2)cn1 Show InChI InChI=1S/C20H19N5O2S/c1-2-4-16(5-3-1)27-18-7-6-17-19(24-18)28-20(23-17)22-14-12-21-25(13-14)15-8-10-26-11-9-15/h1-7,12-13,15H,8-11H2,(H,22,23)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM473761 (US10844077, Compound III-8) Show SMILES C1CC(CCO1)n1cc(Nc2nc3ccc(Oc4ccccc4)nc3s2)cn1 Show InChI InChI=1S/C20H19N5O2S/c1-2-4-16(5-3-1)27-18-7-6-17-19(24-18)28-20(23-17)22-14-12-21-25(13-14)15-8-10-26-11-9-15/h1-7,12-13,15H,8-11H2,(H,22,23)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase HCK (Homo sapiens (Human))	BDBM473760 (US10844077, Compound III-7) Show SMILES Cn1cc(Nc2nc3ccc(Oc4ccccc4)nc3s2)cn1 Show InChI InChI=1S/C16H13N5OS/c1-21-10-11(9-17-21)18-16-19-13-7-8-14(20-15(13)23-16)22-12-5-3-2-4-6-12/h2-10H,1H3,(H,18,19)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM473760 (US10844077, Compound III-7) Show SMILES Cn1cc(Nc2nc3ccc(Oc4ccccc4)nc3s2)cn1 Show InChI InChI=1S/C16H13N5OS/c1-21-10-11(9-17-21)18-16-19-13-7-8-14(20-15(13)23-16)22-12-5-3-2-4-6-12/h2-10H,1H3,(H,18,19)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
Dana-Farber Cancer Institute, Inc. US Patent					Assay Description The inhibitory activities of exemplary compounds described herein against select protein kinases.				US Patent US10844077 (2020) BindingDB Entry DOI: 10.7270/Q2862KJ4
					More data for this Ligand-Target Pair